ArticleCell regeneration (London, England)2026
Mammalian mesenchymal stromal cells enhance zebrafish fin regeneration.
Article in Cell regeneration (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroimmune regulation of post-traumatic bone regeneration: focus on inflammatory switching and functional recovery.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Mesenchymal stromal cells (MSCs) possess well-described immunoregulatory properties, yet their capacity to drive regeneration in vertebrates is still debated and their mechanisms of action remain to be fully elucidated. In this study, we used zebrafish larvae, a highly regenerative vertebrate model to study the effects of MSC delivery on caudal fin fold regeneration and monitored macrophage dynamics through live imaging in fluorescent reporter lines. We found that MSCs enhanced fin regeneration by increasing the early recruitment of inflammatory (tnfa +) macrophages at 1-day-post-amputation (dpA), and accelerating resolution between 2 and 3 dpA. Given the established role of prostaglandin E2 (PGE2) in MSC-mediated immunoregulation, we examined its contribution using indomethacin, a cyclooxygenase inhibitor that suppresses PGE2 production in grafted MSCs. We observed that PGE2 inhibition abolished the pro-regenerative effect of MSCs and maintained elevated tnfa + macrophage levels. PGE2-inhibited MSCs were more susceptible to phagocytosis by both zebrafish and mammalian macrophages, while maintaining viability, indicating a loss of PGE2-mediated protection in treated cells. Together, these findings demonstrate that MSC-derived PGE2 is essential for MSC regenerative function by promoting MSC persistence and modulating macrophage behavior, highlight the zebrafish as a powerful in vivo platform to dissect stem cell-immune interactions and optimize MSC-based regenerative strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.